{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:01Z","timestamp":1772165701473,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04754-y","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:52:54Z","timestamp":1768812774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of everolimus pharmacokinetic monitoring based on trough concentration and area under the blood concentration time curve in kidney transplantation"],"prefix":"10.1186","volume":"27","author":[{"given":"Shota","family":"Fukae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Nonomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"4754_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"M Guba","year":"2002","unstructured":"Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8:128\u201335. https:\/\/doi.org\/10.1038\/nm0202-128.","journal-title":"Nat Med"},{"key":"4754_CR2","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.transproceed.2008.10.011","volume":"40","author":"AG Contreras","year":"2008","unstructured":"Contreras AG, Dormond O, Edelbauer M, Calzadilla K, Hoerning A, Pal S, et al. mTOR-understanding the clinical effects. Transpl Proc. 2008;40:S9\u201312. https:\/\/doi.org\/10.1016\/j.transproceed.2008.10.011.","journal-title":"Transpl Proc"},{"issue":"suppl_3","key":"4754_CR3","doi-asserted-by":"publisher","first-page":"iii9","DOI":"10.1093\/ndt\/gfl295","volume":"21","author":"H Eisen","year":"2006","unstructured":"Eisen H. Long-term cardiovascular risk in transplantation-insights from the use of everolimus in heart transplantation. Nephrol Dialysis Transplant. 2006;21(suppl_3):iii9\u201313. https:\/\/doi.org\/10.1093\/ndt\/gfl295.","journal-title":"Nephrol Dialysis Transplant"},{"key":"4754_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","volume":"371","author":"JA Ormiston","year":"2008","unstructured":"Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(08)60415-8.","journal-title":"The Lancet"},{"key":"4754_CR5","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1128\/JVI.01913-10","volume":"85","author":"AJ Clippinger","year":"2011","unstructured":"Clippinger AJ, Maguire TG, Alwine JC. The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection. J Virol. 2011;85:3930\u201339. https:\/\/doi.org\/10.1128\/JVI.01913-10.","journal-title":"J Virol"},{"key":"4754_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-6143.2011.03826.x","volume":"12","author":"F Cortazar","year":"2012","unstructured":"Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, et al. Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. Am J Transplant. 2012;12:379\u201387. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03826.x.","journal-title":"Am J Transplant"},{"key":"4754_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/00007890-200203270-00016","volume":"73","author":"JM Kovarik","year":"2002","unstructured":"Kovarik JM, Kaplan B, Tedesco Silva H, Kahan BD, Dantal J, Vitko S, et al. Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range. Transplantation. 2002;73:920\u201325. https:\/\/doi.org\/10.1097\/00007890-200203270-00016.","journal-title":"Transplantation"},{"key":"4754_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S1053-2498(02)01221-4","volume":"22","author":"JM Kovarik","year":"2003","unstructured":"Kovarik JM, Eisen H, Dorent R, Mancini D, Vigano M, Rouilly M, et al. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. J Heart Lung Transplant. 2003;22:1117\u201325. https:\/\/doi.org\/10.1016\/S1053-2498(02)01221-4.","journal-title":"The J Heart And Lung Transplant"},{"key":"4754_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1067\/mcp.2001.118022","volume":"70","author":"J Kovarik","year":"2001","unstructured":"Kovarik J. Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications. Clin Pharmacol Ther. 2001;70:247\u201354. https:\/\/doi.org\/10.1067\/mcp.2001.118022.","journal-title":"Clin Pharmacol Ther"},{"key":"4754_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mcp.2001.112969","volume":"69","author":"J Kovarik","year":"2001","unstructured":"Kovarik J. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Clin Pharmacol Ther. 2001;69:48\u201356. https:\/\/doi.org\/10.1067\/mcp.2001.112969.","journal-title":"Clin Pharmacol Ther"},{"key":"4754_CR11","first-page":"169","volume":"10","author":"K Budde","year":"2005","unstructured":"Budde K, Fritsche L, Waiser J, Glander P, Slowinski T, Neumayer H-H, et al. Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients. Eur J Med Res. 2005;10:169\u201374.","journal-title":"Eur J Med Res"},{"key":"4754_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1124\/dmd.122.001066","volume":"51","author":"KD Jackson","year":"2023","unstructured":"Jackson KD, Achour B, Lee J, Geffert RM, Beers JL, Latham BD. Novel approaches to characterize individual drug metabolism and advance precision Medicine. Drug Metab and Dispos. 2023;51:1238\u201353. https:\/\/doi.org\/10.1124\/dmd.122.001066.","journal-title":"Drug Metab and Dispos"},{"key":"4754_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1006\/jmbi.1993.1012","volume":"229","author":"GD Van Duyne","year":"1993","unstructured":"Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J. Atomic structures of the Human Immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol. 1993;229:105\u201324. https:\/\/doi.org\/10.1006\/jmbi.1993.1012.","journal-title":"J Mol Biol"},{"key":"4754_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807\u201315. https:\/\/doi.org\/10.1016\/0092-8674(91)90124-H.","journal-title":"Cell"},{"key":"4754_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.bcp.2008.12.009","volume":"77","author":"HH van Rossum","year":"2009","unstructured":"van Rossum HH, Romijn FPHTM, Smit NPM, de Fijter JW, van Pelt J. Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12. Biochem Pharmacol. 2009;77:1206\u201312. https:\/\/doi.org\/10.1016\/j.bcp.2008.12.009.","journal-title":"Biochem Pharmacol"},{"key":"4754_CR16","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1111\/cts.13389","volume":"15","author":"K Itohara","year":"2022","unstructured":"Itohara K, Yano I, Nakagawa S, Sugimoto M, Hirai M, Yonezawa A, et al. Population pharmacokinetics of everolimus in adult liver transplant patients: comparison to tacrolimus disposition and extrapolation to pediatrics. Clin Transl Sci. 2022;15:2652\u201362. https:\/\/doi.org\/10.1111\/cts.13389.","journal-title":"Clin Transl Sci"},{"key":"4754_CR17","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1681\/ASN.V212s238","volume":"2","author":"JD Pirsch","year":"1992","unstructured":"Pirsch JD, D\u2019Alessandro AM, Sollinger HW, Knechtle SJ, Reed A, Kalayoglu M, et al. Hyperlipidemia and transplantation. J Am Soc of Nephrol. 1992;2:S238. https:\/\/doi.org\/10.1681\/ASN.V212s238.","journal-title":"J Am Soc Of Nephrol"},{"key":"4754_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2337\/db09-1324","volume":"59","author":"VP Houde","year":"2010","unstructured":"Houde VP, Br\u00fbl\u00e9 S, Festuccia WT, Blanchard P-G, Bellmann K, Deshaies Y, et al. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes. 2010;59:1338\u201348. https:\/\/doi.org\/10.2337\/db09-1324.","journal-title":"Diabetes"},{"key":"4754_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","volume":"28","author":"B Kaplan","year":"2014","unstructured":"Kaplan B, Qazi Y, Wellen JR. Strategies for the management of adverse events associated with mTOR inhibitors. Transpl Rev. 2014;28:126\u201333. https:\/\/doi.org\/10.1016\/j.trre.2014.03.002.","journal-title":"Transpl Rev"},{"key":"4754_CR20","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1111\/ajt.12852","volume":"14","author":"N Murakami","year":"2014","unstructured":"Murakami N, Riella LV, Funakoshi T. Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: a systematic review and meta-analysis. Am J Transpl. 2014;14:2317\u201327. https:\/\/doi.org\/10.1111\/ajt.12852.","journal-title":"Am J Transpl"},{"key":"4754_CR21","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1600-6143.2008.02272.x","volume":"8","author":"BL Kasiske","year":"2008","unstructured":"Kasiske BL, de Mattos A, Flechner SM, Gallon L, Meier-Kriesche H-U, Weir MR, et al. Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients. Am J Transpl. 2008;8:1384\u201392. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02272.x.","journal-title":"Am J Transpl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04754-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04754-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04754-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:29:44Z","timestamp":1770838184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04754-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4754"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04754-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7986395\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Institutional Review Board (Osaka University Hospital Institutional Review Board, protocol number: 21374) before initiating the study, and all patients provided written informed consent. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"111"}}